XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Note 21 - Share-based Compensation Expenses
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]
 

21.

Share-based compensation expenses

 

For the six and three months ended June 30, 2024, the Company did not record any share-based compensation expenses.

 

 

In April 2023, under its 2020 Omnibus Securities and Incentive Plan, the Company granted and issued 0.03 million fully-vested shares of the Company’s restricted common stock to one of its independent directors in exchange for his service to the Company for the year ending December 31, 2023. These shares were valued at US$1.65 per share, the closing bid price of the Company’s common stock on the grant date. Total compensation expenses amortized for the six and three months ended June 30, 2023 was approximately US$0.02 million.

 

In June 2022, the Company granted and issued 0.08 million fully-vested and non-forfeitable shares of the Company restricted common stock to a management consulting and advisory service provider in exchange for its service for a 12-month period until May 2023. The Company valued these shares at US$1.75 per share, the closing bid price of the Company’s common stock on the grant date of these shares and recorded the related total cost of approximately US$0.14 million as a prepayment asset in prepayment and deposit to suppliers account upon the grant and issuance of these shares. Total compensation expenses amortized for the six and three months ended June 30, 2023 was approximately US$0.06 million and US$0.02 million, respectively.

 

The table below summarized share-based compensation expenses recorded for the six and three months ended June 30, 2024 and 2023, respectively:

 

   

Six Months Ended June 30,

   

Three Months Ended June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

US$(’000)

   

US$(’000)

   

US$(’000)

   

US$(’000)

 
   

(Unaudited)

   

(Unaudited)

   

(Unaudited)

   

(Unaudited)

 
                                 

Sales and marketing expenses

    -       -       -       -  

General and administrative expenses

    -       83       -       48  

Research and development expenses

    -       -       -       -  

Total

    -       83       -       48